These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2991215)

  • 1. Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.
    Spector T; Jones TE
    J Biol Chem; 1985 Jul; 260(15):8694-7. PubMed ID: 2991215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
    Sato A; Bacon PE; Cory JG
    Adv Enzyme Regul; 1984; 22():231-41. PubMed ID: 6089512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus ribonucleotide reductase induced in infected BHK-21/C13 cells: biochemical evidence for the existence of two non-identical subunits, H1 and H2.
    Cohen EA; Charron J; Perret J; Langelier Y
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():733-45. PubMed ID: 2984316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver microsomal inactivation of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone as an inhibitor of ribonucleotide reductase.
    Williams MT; Simonet L; Cory AH; Cory JG
    Cancer Res; 1988 Nov; 48(22):6375-8. PubMed ID: 3052801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of combinations of drugs that inhibit Ehrlich tumor cell ribonucleotide reductase.
    Sato A; Cory JG
    Cancer Res; 1981 May; 41(5):1637-41. PubMed ID: 6783298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribonucleotide reductase induced by herpes simplex type 1 virus. Characterization of a distinct enzyme.
    Averett DR; Lubbers C; Elion GB; Spector T
    J Biol Chem; 1983 Aug; 258(16):9831-8. PubMed ID: 6309786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).
    Moore EC; Hurlbert RB
    Pharmacol Ther; 1985; 27(2):167-96. PubMed ID: 3898152
    [No Abstract]   [Full Text] [Related]  

  • 8. Ribonucleotide reductase of herpes simplex virus type 2 resembles that of herpes simplex virus type 1.
    Averett DR; Furman PA; Spector T
    J Virol; 1984 Dec; 52(3):981-3. PubMed ID: 6092726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy.
    Cory JG; Fleischer AE
    Cancer Res; 1979 Nov; 39(11):4600-4. PubMed ID: 498090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells.
    Lewis WH; Wright JA
    J Cell Physiol; 1978 Oct; 97(1):87-97. PubMed ID: 568630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ribonucleotide reductase activity and nucleic acid synthesis in tumor cells by the dialdehyde derivatives of inosine (NSC 118994) and inosinic acid.
    Cory JG; Mansell MM; Whitford TW
    Cancer Res; 1976 Sep; 36(9 pt.1):3166-70. PubMed ID: 987850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
    Cory AH; Sato A; Thompson DP; Cory JG
    Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ribonucleotide reductases encoded by herpes simplex viruses.
    Spector T
    Pharmacol Ther; 1985; 31(3):295-302. PubMed ID: 3035588
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpes simplex virus type 1 ribonucleotide reductase: selective and synergistic inactivation by A1110U and its iron complex.
    Porter DJ; Harrington JA; Spector T
    Biochem Pharmacol; 1990 Feb; 39(4):639-46. PubMed ID: 2154988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
    Carter GL; Cory JG
    Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture.
    Matsumoto M; Tihan T; Cory JG
    Cancer Chemother Pharmacol; 1990; 26(5):323-9. PubMed ID: 2208572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes and human ribonucleotide reductases. Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87).
    Spector T; Harrington JA; Porter DJ
    Biochem Pharmacol; 1991 Jun; 42(1):91-6. PubMed ID: 1648925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy.
    Cory JG; Sato A; Lasater L
    Adv Enzyme Regul; 1980; 19():139-50. PubMed ID: 7039256
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationships between sensitivity to hydroxyurea and 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIO) and ribonucleotide reductase RNR2 mRNA levels in strains of Saccharomyces cerevisiae.
    Rittberg DA; Wright JA
    Biochem Cell Biol; 1989 Jul; 67(7):352-7. PubMed ID: 2675933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.
    Preidecker PJ; Agrawal KC; Sartorelli AC; Moore EC
    Mol Pharmacol; 1980 Nov; 18(3):507-12. PubMed ID: 7007866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.